Yino
Advancing Oncology Radiotherapy with Pioneering Clinical Technology
Advancing Oncology Radiotherapy with Pioneering Clinical Technology
Yino is a groundbreaking company in the field of oncology radiotherapy, with a slogan that emphasizes its commitment to advancing this important technology. Since its founding in 2004, Yino has prioritized the development of clinical technology for oncology radiotherapy, aiming to enhance the interaction between doctors and patients while promoting the use of radiation technology for the treatment of tumors. The company's recent Series C investment of CNY30.00M in October 18, 2016 from SZ Capital demonstrates the confidence that investors have in Yino's innovative approach. As a leader in the information technology sector, Yino is poised to make significant contributions to the advancement of oncology treatment and patient care.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | CNY30.00M | 1 |
|
18 Oct 2016 |
| Series B | CNY55.00M | 3 |
|
17 Dec 2015 |
| Series A | CNY20.00M | 1 |
|
31 Dec 2014 |
| Angel Round | CNY13.00M | 1 |
|
12 Sep 2013 |
No recent news or press coverage available for Yino.
We care about your data, and we'd love to use cookies make your experience better.
